Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
Akronym
HoloSurge
Bidragets beskrivning
Perioperative care is an intricate process that encompasses 1) preoperative evaluation, surgical planning and preparation; 2) intraoperative procedure; and 3) postoperative management. Perioperative care depends on clinical decision-making, a continuous process that involves many healthcare professionals (incl. radiologists, surgeons, anaesthesiologists, nurses, and others) who – based on the best available evidence, clinical experience, and the patient's individual circumstances – make informed decisions on the best course of action. Even though advancements in medical imaging modalities (CT, MRI, ultrasound) have greatly improved surgical outcomes, their interpretation towards deciding a specific course of action remains subjective. In addition, these modalities have several limitations when used alone (e.g., missed lesions; cannot provide a 3D visualization of key structures such as vessels), ultimately failing to provide a full picture of the patient’s anatomy that is shared and unambiguously understood by all in the assigned team. Due to these limitations, there are often suboptimal decisions that add to a cumulative risk of surgical complications in perioperative care.
HoloSurge is a joint undertaking that brings European scientists and clinicians from high-tech companies, clinical centres, and research institutions in a consortium to deploy an innovative AI-based medical system that: i) enables automatic fusion and segmentation of state-of-the-art imaging modalities for interactive 3D holographic visualization of patients’ organs; ii) provides real-time surgical navigation; and iii) allows real-time cell-level cancer diagnostics. The solution will provide surgical teams with an unmatched holistic view of the patient’s anatomy and pathology in real-time at point of care, before and during surgery. This innovation will be validated for cancer interventions, while creating a trail of better-informed perioperative decision-making that can save countless lives.
Visa merStartår
2024
Slutår
2027
Beviljade finansiering
UNITED EUROPEAN GASTROENTEROLOGY GMBH (AT)
79 734.38 €
Participant
ORBIT21 CONSULTING LTD (UK)
Participant
HOLOCARE AS (NO)
1 951 978.88 €
Coordinator
DIGESTIVE CANCERS EUROPE DICE (BE)
107 187.5 €
Participant
CYENS CENTRE OF EXCELLENCE (CY)
352 500 €
Participant
SINTEF AS (NO)
1 018 171.25 €
Participant
THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST (UK)
Participant
OSLO UNIVERSITETSSYKEHUS HF (NO)
938 338.75 €
Participant
KLINIKUM DER UNIVERSITAT MUNCHEN (DE)
540 000 €
Third party
NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE -PANSTWOWY INSTYTUT BADAWCZY (PL)
147 737.5 €
Participant
SEMMELWEIS EGYETEM (HU)
Participant
UNIVERSITY OF LEEDS (UK)
Participant
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE)
Participant
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NL)
1 537 581.25 €
Participant
Beviljat belopp
6 806 756 €
Finansiär
Europeiska unionen
Typ av finansiering
HORIZON Innovation Actions
Ramprogram
Horizon Europe (HORIZON)
Utlysning
Programdel
Health (11673 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine (11693 )
Tema
Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery (HORIZON-HLTH-2023-TOOL-05-05Utlysnings ID
HORIZON-HLTH-2023-TOOL-05 Övriga uppgifter
Finansieringsbeslutets nummer
101137233